Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Directory of Open Access Journals kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Dynamics and Half-Life of Cell-Free DNA After Exercise: Insights from a Fragment Size-Specific Measurement Approach

Title: Dynamics and Half-Life of Cell-Free DNA After Exercise: Insights from a Fragment Size-Specific Measurement Approach
Authors: Ryutaro Yamamoto; Hiroshi Asano; Ryo Tamaki; Yoshihiro Saito; Ami Hosokawa; Hidemichi Watari; Takeshi Umazume
Source: Diagnostics, Vol 15, Iss 1, p 109 (2025)
Publisher Information: MDPI AG, 2025.
Publication Year: 2025
Collection: LCC:Medicine (General)
Subject Terms: cell-free DNA; biomarker; circulating; half-life; clearance; fragment size; Medicine (General); R5-920
Description: Background: Cell-free DNA (cfDNA) is present in healthy individuals but is elevated in those undergoing physical exertion, trauma, sepsis, and certain cancers. Maintaining cfDNA concentrations is vital for immune homeostasis and preventing inflammatory responses. Understanding cfDNA release and clearance is essential for using cfDNA as a biomarker in clinical diagnostics. We focused on the fragment size of cfDNA and investigated cfDNA dynamics and half-life, particularly the 100–250 base pair fragments. Methods: Healthy, adult men (n = 5; age 40 ± 4.1 years) were subjected to a 30 min treadmill exercise. Blood samples were collected at 0, 5, 10, 15, 30, and 60 min post-exercise using PAXgene® Blood ccfDNA tubes to stabilize and prevent nuclease-mediated cfDNA degradation and minimize genomic DNA contamination risk. The cfDNA concentration was measured using an electrophoresis-based technique (4150 TapeStation system) to quantify the concentration based on cfDNA fragment size. Results: The results showed a cfDNA half-life of 24.2 min, with a transient increase in 100–250 base pair cfDNA fragments post-exercise, likely due to nuclease activity. These levels rapidly reverted to the baseline within an hour. Conclusions: The rapid clearance of cfDNA underscores its potential as a biomarker for real-time disease monitoring and the evaluation of treatment efficacy. This study is expected to standardize cfDNA investigations, enhancing diagnosis and treatment monitoring across various disease conditions.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2075-4418
Relation: https://www.mdpi.com/2075-4418/15/1/109; https://doaj.org/toc/2075-4418
DOI: 10.3390/diagnostics15010109
Access URL: https://doaj.org/article/c2fd236d0dda4aab84a1ff9c856486ec
Accession Number: edsdoj.2fd236d0dda4aab84a1ff9c856486ec
Database: Directory of Open Access Journals